IUC24414-80

Abstract Code: IUC24414-80 Optimizing Sunitinib Therapy in mRCC Through Pharmacological Counselling and Early TDM Integration   G. Bortolus 1, E. Cecchin 2, S. Gagno 2, B. Posocco 2, A. Dri 3, S. Santarossa 3, G. Toffoli 2, F. Puglisi 4, M. Spina 3, L. Fratino 3 (1)...

IUC24394-87

Abstract Code: IUC24394-87 Meet-URO score update in Metastatic Renal Cell Carcinoma receiving 1st line Immune-Combinations   Pasquale Rescigno1, Aruni Ghose2, Nicholas Brown3, Lijo James4, Sophia Haywood5, Ricky Frazer6, Anupama Vijay7, Mark Stares8, Michael Cheung9,...

IUC24360-80

Abstract Code: IUC24360-80 Second-line therapies of Metastatic Renal Cell Carcinoma (mRCC) after 1st line immune-combinations (ICI-combos) (Meet-URO 33 study)   D. Bimbatti 1, C. Messina 2, L. Bonomi 3, S. Scagliarini 4, S. Chiellino 5, B.A. Maiorano 6, F.M. Deppieri...

IUC24358-87

Abstract Code: IUC24358-87 Prognostic assessment of the Meet-URO score compared with the IMDC score in Metastatic Renal Cell Carcinoma (mRCC) receiving 1st line systemic therapies (Meet-URO 33 study)   S.E. Rebuzzi 1, C. Messina 2, L. Bonomi 3, S. Scagliarini 4, S....

IUC22940-82

Abstract Code: IUC22940-82 A 7-Year Review of Robot-Assisted vs Laparoscopic Radical Nephrectomy at a UK District General Hospital (2018–2024) A. Hossain 1, S. Khan 1, A. Albnhawy 2 (1) Surrey and Sussex Healthcare NHS Trust – United Kingdom, (2) Redhill –...
error: Content is protected !!